Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Affirm Holdings Inc (AFRM) vs TransMedics Group Inc (TMDX) Price & Performance

Affirm Holdings IncTrade
TransMedics Group IncTrade

Price performance (Past 24H)

Key statistics

Affirm Holdings Inc vs TransMedics Group Inc — how do they compare? Affirm Holdings Inc trades at $77.15 (market cap $25.30B), while TransMedics Group Inc trades at $89.69 (market cap $3.07B). The key difference: Affirm Holdings Inc is far larger — about 8.2× TransMedics Group Inc's market cap, and Affirm Holdings Inc is trading nearer its 52-week high, TransMedics Group Inc nearer its low. Which is the better fit depends on your goals.

AFRMTMDX
Market Cap
$25.30B$3.07B
Sector
FinancialsTechnology
52-Week High
$92.18$150.42
52-Week Low
$42.53$61.99
Enterprise Value
$31.91B$3.46B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Affirm Holdings Inc

No Aura AI signal available yet.

TransMedics Group Inc

TMDX trades at $83.89, up 4.59% today, with a bullish technical signal from moving averages and strong support at $81. The company reported a Q2 2026 earnings miss ($0.44 actual vs. $0.50 expected) but beat revenue expectations, with 2025 net income at $190.29M. Analyst consensus is a Buy with a $99.57 price target, though recent news highlights a legal investigation into fiduciary duties.

Outlook remains positive due to raised revenue guidance and institutional interest, but risks include earnings volatility, margin pressure, and legal scrutiny. The stock's valuation multiples suggest growth expectations, yet execution on cost control and international expansion will be critical for sustained upside.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Affirm Holdings Inc

Affirm Holdings Inc offers a platform for digital and mobile first commerce. It comprises a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The firm generates its revenue from merchant networks, and through virtual card networks among others. Geographically, it generates a major share of its revenue from the United States.

Read more on AFRM

About TransMedics Group Inc

TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.

Read more on TMDX